PMID- 37086858 OWN - NLM STAT- MEDLINE DCOM- 20230822 LR - 20230929 IS - 1549-4713 (Electronic) IS - 0161-6420 (Linking) VI - 130 IP - 9 DP - 2023 Sep TI - Immediate Sequential Bilateral Surgery in Refractive Lens Exchange Patients: Clinical Outcomes and Adverse Events. PG - 924-936 LID - S0161-6420(23)00279-8 [pii] LID - 10.1016/j.ophtha.2023.04.013 [doi] AB - PURPOSE: To evaluate outcomes and the incidence of adverse events (AEs) in patients who underwent bilateral same-day refractive lens exchange (RLE). DESIGN: Retrospective case series. PARTICIPANTS: Patients of a private intraocular surgery provider in the United Kingdom who underwent RLE in both eyes on the same day with treatment dates between March 2018 and December 2021. METHODS: Clinical outcomes and AEs were collected for a continuous cohort of patients undergoing bilateral same-day RLE (in the absence of visually significant cataracts) or had mild cataracts (corrected visual acuity >/= 20/40). One-month clinical outcomes were analyzed. MAIN OUTCOME MEASURES: Refractive outcomes and visual acuity, intraoperative and postoperative AEs, and secondary surgical interventions recorded within the first month after surgery. RESULTS: A total of 17 330 patients (34 660 eyes) were included in the analysis. Of these, 28 827 eyes received a multifocal intraocular lens (IOL), and 5833 eyes had a monofocal IOL. The percentage of eyes within +/-0.50 diopters (D) of intended refraction was 85.5% and 86.2% for monofocal and multifocal IOL eyes, respectively. There was a total of 55 intraoperative AEs recorded in 55 eyes of 54 patients (per-eye incidence: 0.159%). Posterior capsule tear was the most common intraoperative event occurring in 37 eyes (0.107%). The number of AEs recorded within the first postoperative month was 267, occurring in 263 eyes of 177 patients (per-eye incidence: 0.759%). These included cystoid macular edema (CME) (172 eyes; 0.496%), significant corneal edema (28 eyes; 0.081%), persistent inflammation (27 eyes; 0.078%), significantly raised intraocular pressure (27 eyes; 0.078%), toxic anterior segment syndrome (8 eyes; 0.023%), wound leak (3 eyes; 0.009%), retinal detachment (1 eye; 0.003%), and retinal tear (1 eye; 0.003%). There were 56 secondary surgical interventions recorded within the first month of surgery, occurring in 54 eyes of 47 patients (per-eye incidence: 0.156%). The most common secondary intervention was the rotation of a misaligned toric IOL (24 eyes; 0.069%). CONCLUSIONS: Elective same-day bilateral RLE had a low incidence of serious AEs, and high refractive predictability. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article. CI - Copyright (c) 2023 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. FAU - Hannan, Stephen J AU - Hannan SJ AD - Optical Express, Glasgow, United Kingdom. FAU - Schallhorn, Steven C AU - Schallhorn SC AD - Optical Express, Glasgow, United Kingdom; University of California, San Francisco, Department of Ophthalmology, San Francisco, California; Carl Zeiss Meditec, Inc., Dublin, California. FAU - Venter, Jan A AU - Venter JA AD - Optical Express, Glasgow, United Kingdom. FAU - Teenan, David AU - Teenan D AD - Optical Express, Glasgow, United Kingdom. FAU - Schallhorn, Julie M AU - Schallhorn JM AD - University of California, San Francisco, Department of Ophthalmology, San Francisco, California; F.I. Proctor Foundation, University of California, San Francisco, California. Electronic address: Julie.schallhorn@ucsf.edu. LA - eng PT - Journal Article DEP - 20230420 PL - United States TA - Ophthalmology JT - Ophthalmology JID - 7802443 SB - IM MH - Humans MH - Retrospective Studies MH - Lens Implantation, Intraocular MH - Visual Acuity MH - Refraction, Ocular MH - *Lenses, Intraocular/adverse effects MH - *Cataract MH - *Phacoemulsification/adverse effects OTO - NOTNLM OT - Immediate sequential bilateral surgery OT - Refractive lens exchange OT - Secondary interventions OT - Surgical adverse events EDAT- 2023/04/23 00:41 MHDA- 2023/08/22 06:43 CRDT- 2023/04/22 19:25 PHST- 2023/01/18 00:00 [received] PHST- 2023/04/06 00:00 [revised] PHST- 2023/04/13 00:00 [accepted] PHST- 2023/08/22 06:43 [medline] PHST- 2023/04/23 00:41 [pubmed] PHST- 2023/04/22 19:25 [entrez] AID - S0161-6420(23)00279-8 [pii] AID - 10.1016/j.ophtha.2023.04.013 [doi] PST - ppublish SO - Ophthalmology. 2023 Sep;130(9):924-936. doi: 10.1016/j.ophtha.2023.04.013. Epub 2023 Apr 20.